M. Charbonneau

Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria

R. Stevens, P. Fitzpatrick, J. Lemontt, 2008, Proceedings of the National Academy of Sciences.

Null mutation of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity.

A. Hilliker, J. Phillips, S. Campbell, 1989, Proceedings of the National Academy of Sciences of the United States of America.

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding

S. Trudel, J. Koropatnick, S. Viau, 2016, Clinical Cancer Research.

Abstract 2646: Intratumoral delivery of TTI-621 (SIRPαFc), a CD47-blocking immunotherapeutic, inhibits tumor growth and prolongs animal survival in a subcutaneous B cell lymphoma model

G. Lin, L. D. Johnson, Bolette Bossen, 2017 .

Abstract 3854: Preclinical characterization of a novel non-cyclic dinucleotide small molecule STING agonist with potent antitumor activity in mice

V. Lee, Zezhou Wang, G. Lin, 2019, Experimental and Molecular Therapeutics.

Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria

R. Stevens, P. Fitzpatrick, J. Lemontt, 2008, Proceedings of the National Academy of Sciences.